Literature DB >> 2051522

Serological evidence of arboviral infections among humans of coastal Kenya.

J C Morrill1, B K Johnson, C Hyams, F Okoth, P M Tukei, M Mugambi, J Woody.   

Abstract

A serosurvey was conducted during September 1987 for evidence of human arboviral infections in the Coast Province of Kenya. Sera were collected from 1624 outpatients at three hospitals and tested for antibody to eight arboviruses by the indirect immunofluorescent antibody technique. Antibody prevalence rates were: Rift Valley fever, 2.8%; Sindbis, 2.6%; dugbe, 2.1%; dengue-2, 1.0%; West Nile, 0.9%; chikungunya, 0.7% and Nairobi sheep disease, 0.3%. Evidence of Crimean-Congo haemorrhagic fever viral antibody was not detected. The data suggested low arbovirus activity since 1982, when an epidemic of dengue occurred in this region, and revealed the first evidence of dugbe viral infection among humans in Kenya.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2051522

Source DB:  PubMed          Journal:  J Trop Med Hyg        ISSN: 0022-5304


  19 in total

1.  Serologic evidence of arboviral infections among humans in Kenya.

Authors:  Laura J Sutherland; Ayla A Cash; Yan-Jang Scott Huang; Rosemary C Sang; Indu Malhotra; Ann M Moormann; Christopher L King; Scott C Weaver; Charles H King; A Desiree LaBeaud
Journal:  Am J Trop Med Hyg       Date:  2011-07       Impact factor: 2.345

2.  Severe Rift Valley fever may present with a characteristic clinical syndrome.

Authors:  Summerpal S Kahlon; Clarence J Peters; James Leduc; Eric M Muchiri; Samuel Muiruri; M Kariuki Njenga; Robert F Breiman; A Clinton White; Charles H King
Journal:  Am J Trop Med Hyg       Date:  2010-03       Impact factor: 2.345

3.  Predictors of human-infective RNA virus discovery in the United States, China, and Africa, an ecological study.

Authors:  Feifei Zhang; Margo Chase-Topping; Chuan-Guo Guo; Mark E J Woolhouse
Journal:  Elife       Date:  2022-06-06       Impact factor: 8.713

Review 4.  Rift valley fever vaccines.

Authors:  Tetsuro Ikegami; Shinji Makino
Journal:  Vaccine       Date:  2009-11-05       Impact factor: 3.641

5.  First serological evidence of West Nile virus in human rural populations of Gabon.

Authors:  Xavier Pourrut; Dieudonné Nkoghé; Janusz Paweska; Eric Leroy
Journal:  Virol J       Date:  2010-06-17       Impact factor: 4.099

6.  Spectrum of Rift Valley fever virus transmission in Kenya: insights from three distinct regions.

Authors:  A Desiree LaBeaud; Yoshitsugu Ochiai; C J Peters; Eric M Muchiri; Charles H King
Journal:  Am J Trop Med Hyg       Date:  2007-05       Impact factor: 2.345

7.  Seroprevalence and distribution of arboviral infections among rural Kenyan adults: a cross-sectional study.

Authors:  Luke E Mease; Rodney L Coldren; Lillian A Musila; Trish Prosser; Fredrick Ogolla; Victor O Ofula; Randal J Schoepp; Cindy A Rossi; Nicholas Adungo
Journal:  Virol J       Date:  2011-07-27       Impact factor: 4.099

8.  Arbovirus prevalence in mosquitoes, Kenya.

Authors:  A Desiree LaBeaud; Laura J Sutherland; Samuel Muiruri; Eric M Muchiri; Laurie R Gray; Peter A Zimmerman; Amy G Hise; Charles H King
Journal:  Emerg Infect Dis       Date:  2011-02       Impact factor: 6.883

9.  A household serosurvey to estimate the magnitude of a dengue outbreak in Mombasa, Kenya, 2013.

Authors:  Esther M Ellis; John C Neatherlin; Mark Delorey; Melvin Ochieng; Abdinoor Haji Mohamed; Daniel Ondari Mogeni; Elizabeth Hunsperger; Shem Patta; Stella Gikunju; Lilian Waiboic; Barry Fields; Victor Ofula; Samson Limbaso Konongoi; Brenda Torres-Velasquez; Nina Marano; Rosemary Sang; Harold S Margolis; Joel M Montgomery; Kay M Tomashek
Journal:  PLoS Negl Trop Dis       Date:  2015-04-29

10.  Interepidemic Rift Valley fever virus seropositivity, northeastern Kenya.

Authors:  A Desiree LaBeaud; Eric M Muchiri; Malik Ndzovu; Mariam T Mwanje; Samuel Muiruri; Clarence J Peters; Charles H King
Journal:  Emerg Infect Dis       Date:  2008-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.